News and Media

Through interviews, speaking engagements, conference participation, and published research, GMO provides insights that generate robust conversations.

In the News

Jeremy Grantham appeared on CNBC's "The Exchange", (May 18, 2022) with Kelly Evans to discuss the Fed, historical bubbles, and how he sees comparisons to 2000 in today’s markets.

Jeremy Grantham on Bloomberg Front Row (January 26, 2022): ’Calling A Super Bubble.’

Jeremy Grantham’s January 2022 paper ‘Let The Wild Rumpus Begun’ received media coverage from outlets including Bloomberg, CNBC, Financial Times, MarketWatch and Citywire.

Ben Inker appears on ‘Barron’s Live’ (January 24, 2022): ‘The Outlook for U.S. Stocks and Bonds: Talking with GMO's Ben Inker.’

Tina Vandersteel appears on Bloomberg’s Masters in Business podcast discussing emerging markets debt investing (January 21, 2022).

Scott Hayward featured in Institutional Investor’s coverage of CFA Institute’s DEI Code (March 22, 2022): ‘CalPERS, GMO, MassPRIM, and More Commit to CFA Institute’s DEI Code.’

John Thorndike interviewed by Institutional Investor (April 14, 2022): ‘GMO: Value Outperformed Growth in the First Quarter. That Doesn’t Mean It’s Over.’

Tom Hancock and the GMO Quality Fund profiled by Australian Financial Review (February 22, 2022): ‘Why this US fund manager is bullish on Taiwan chipmaker.’

Jeremy Grantham’s April 2022 paper on Putin’s invasion and Resources covered by Bloomberg, FT Alphaville, Insider, MarketWatch, The Acquirer’s Multiple and Advisor Perspectives

Binu George and GMO EM Ex-China featured in Bloomberg Markets Magazine (January 27, 2022): ‘Stripping China From Emerging Markets Is Wall Street's New Craze.’

James Montier featured in Citywire Q&A on the inflation debate and the best way to guard against rising prices (December 7, 2021).

Jeremy Grantham appears on Citywire’s Mistakes Were Made podcast (November 25, 2021).

Ben Inker appears on Validea’s Excess Returns podcast (September 27, 2021): ‘Dispelling Myths in the Value vs. Growth Debate.’

Ben Inker appears on Bloomberg Surveillance (September 1, 2021) discussing value stocks being left behind for no good reason.

Jeremy Grantham appears on CNBC Closing Bell to discuss the markets, ESG investing and the future of green energy (September 28, 2021).

Jeremy Grantham’s fireside chat with Morningstar CEO Kunal Kapoor at the Morningstar Investment Conference in Australia (June 2021) was covered by Morningstar, Australian Financial Review, Firstlinks, The Australian, Bloomberg and Insider, among others.

Lucas White featured in the Barron’s Q&A (April 30, 2021): ‘A Fund Cleans Up by Betting on Clean Energy’.

Ben Inker appears on Bloomberg’s Masters in Business podcast with Barry Ritholtz, discussing value investing and asset allocation in the midst of an overvalued market (February 12, 2021).

Jeremy Grantham appears on Patrick O’Shaughnessy’s Invest Like The Best podcast (February 23, 2021).

Jeremy Grantham appears on The Meb Faber podcast discussing one of the great bubbles in financial history (February 8, 2021).

Jeremy Grantham feature interview in Financial Advisor (April 13, 2021): ‘Grantham Sees A Trifecta Of Bubbles’

Lucas White appears on The Meb Faber podcast discussing GMO Climate Change and GMO Resources (January 11, 2021).

Ben Inker speaks to Institutional Investor (December 8, 2020) on the launch of the GMO Equity Dislocation strategy and the GMO Quarterly Letter in ‘GMO Has a Plan to Profit From a Growth Stock Bubble

Lucas White quoted in Kiplinger’s Personal Finance on climate change investing (February 28, 2021): ‘Profit From Planet-Friendly Companies’

Jeremy Grantham’s January 2021 Viewpoints piece “Waiting for the Last Dance” was covered by The Financial Times, Bloomberg, Barron’s, Institutional Investor, The Economist, Business Insider, CNN Business, Financial Advisor, Yahoo Finance, CNBC, The Sydney Morning Herald and The Irish Times, among other publications.

Ben Inker appears on Morningstar’s ‘The Long View’ podcast with hosts Christine Benz and Jeff Ptak (July 29, 2020): ‘Ben Inker: 'The Portfolio We're Running Today Is Abnormal Even for Us'